Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
Katariina Öörni, Professor of Integrative Physiology at University of Helsinki, shared a post on LinkedIn about a recent article she and her colleagues co-authored:
“Our latest study, published in the JIM – Journal of Internal Medicine, examines the role of cholesterol absorption efficiency in atherosclerosis.
Traditionally, CVD risk assessment focuses on circulating cholesterol levels, but how cholesterol is handled in the body may be as important.
We observed that:
Individuals with high cholesterol absorption efficiency had
- increased LDL aggregation susceptibility
- increased proteoglycan-binding efficiency
despite similar LDL-cholesterol levels between high and low cholesterol absorbers.
High cholesterol absorption efficiency was associated with distinct LDL lipidome.
Why this matters
The functional properties of LDL particles related to particle aggregation and binding to proteoglycans play a role in the development of atherosclerotic plaques.
Our data may help explain why:
- Some individuals develop ASCVD despite ‘normal’ lipid profiles
- Measurement of LDL-cholesterol alone does not fully capture cardiovascular risk
A shift in perspective
Instead of focusing solely on LDL concentration, we may need to think more about:
- LDL function
- Lipid composition
This is where lipidomics and mechanistic studies can meaningfully complement clinical lipid measurements.”
Title: High cholesterol absorption efficiency enhancesproatherogenic properties of low-density lipoproteinparticles
Authors: Katariina Öörni, Lauri Äikäs, Maija Ruuth, Feven Tigistu-Sahle, Reijo Käkelä, Ingmar Wester, Helena Gylling, Piia Simonen
Read the Full Article on JIM
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026